pHLIP Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

pHLIP General Information

Description

Developer of a drug-targeting platform designed to treat diseases characterized by acidic tissues. The company's platform offers pHLIP peptides that selectively target acidic environments in conditions such as cancer, inflammation, and fibrosis, enabling clinicians to improve patient outcomes and save lives through peptide-based targeted delivery systems for diagnosing and treating diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 2 Lippitt Road
  • Kingston, RI 02881
  • United States
+1 (833)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 2 Lippitt Road
  • Kingston, RI 02881
  • United States
+1 (833)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

pHLIP Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Jun-2025 Completed Clinical Trials - General
3. Early Stage VC 29-Oct-2018 Completed Clinical Trials - General
2. Accelerator/Incubator 01-Jan-2018 $50K $2.02M Completed Clinical Trials - General
1. Seed Round 05-Sep-2017 $1.98M $1.98M Completed Clinical Trials - General
To view pHLIP’s complete valuation and funding history, request access »

pHLIP Patents

pHLIP Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025171027-A1 Phlip ®-lnp for targeted intracellular delivery of nucleic acid therapeutics Pending 05-Feb-2024
AU-2021347150-A1 Radiolabeled ligands for targeted pet/spect imaging and methods of their use Pending 22-Sep-2020
CA-3193223-A1 Radiolabeled ligands for targeted pet/spect imaging and methods of their use Pending 22-Sep-2020
EP-4216981-A1 Radiolabeled ligands for targeted pet/spect imaging and methods of their use Pending 22-Sep-2020
EP-4216981-A4 Radiolabeled ligands for targeted pet/spect imaging and methods of their use Pending 22-Sep-2020 A61K51/088
To view pHLIP’s complete patent history, request access »

pHLIP FAQs

  • When was pHLIP founded?

    pHLIP was founded in 2014.

  • Where is pHLIP headquartered?

    pHLIP is headquartered in Kingston, RI.

  • What industry is pHLIP in?

    pHLIP’s primary industry is Drug Discovery.

  • Is pHLIP a private or public company?

    pHLIP is a Private company.

  • What is pHLIP’s current revenue?

    The current revenue for pHLIP is .

  • How much funding has pHLIP raised over time?

    pHLIP has raised $6.44M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process